iCare IC1000 Alignment Study

The primary objective of this study is to evaluate the performance of the alignment feature of iCare IC1000 tonometer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intraocular Pressure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clear Vue Laser Eye Center

Lake Worth, Florida, 33467, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age ≥ 18 years

Exclusion criteria

Subjects with only one functional eye
Central corneal scarring
Microphthalmos
Buphthalmos
Contact lens use during measurement or hard lenses 24h prior to measurement
Dry eyes (clinically significant)
Nystagmus
Keratoconus
Any other corneal or conjunctival pathology or infection relevant to this study
Coloboma or other pupil deformation

Treatment and study plan

iCare IC1000 measurement

Device

Measurement of intraocular pressure with iCare IC1000

Primary outcomes

Primary Objective

Time frame: Through study completion, an average of 2 months

Number of participants with successful intraocular pressure (IOP) measurements using the alignment feature of the iCare IC1000 tonometer during a single clinic visit.

Sponsors and collaborators

Lead sponsor

Icare Finland Oy

Industry

Registry information

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Jun 15, 2025
Registry last updated: Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed